Return to content in this issue

 

EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma

Plaza V1, Eguíluz I2, Garin N3, Martínez Moragón E4, Palomares Ó5, Dávila I6

1Director of the Executive Committee of the Spanish Guide for the Management of Asthma (GEMA), Pneumology and Allergy Service, Hospital de la Santa Creu i Sant Pau, Sant Pau Institute of Biomedical Research (IIB Sant Pau); Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
2Allergy Unit and Research Laboratory, Málaga Regional University Hospital and IBIMA-Plataforma BIONAND; RICORS Inflammatory Diseases Network, Málaga, Spain
3Department of Pharmacy, Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona, Barcelona, Spain
4Pneumology Service, Dr Peset University Hospital, Valencia, Spain
5Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain
6Allergy Service, University Hospital of Salamanca. Biomedical and Diagnostics Sciences, Faculty of Medicine, University of Salamanca; RICORS Inflammatory Diseases Network RD21/0002/000, Salamanca, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(5) : 336-338
doi: 10.18176/jiaci.0997

Key words: Alarmins, Epithelium, Pathogenesis, Tezepelumab, Treatment